Quadrant Capital Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91K Sell
538
-1,211
-69% -$7.25K ﹤0.01% 2455
2025
Q4
$12.2K Buy
1,749
+964
+123% +$6.34K ﹤0.01% 2153
2025
Q3
$5.06K Buy
+785
New +$5.37K ﹤0.01% 2319
2025
Q2
Sell
-4,085
Closed -$26.4K 1494
2025
Q1
$26.4K Sell
4,085
-48
-1% -$345 ﹤0.01% 1948
2024
Q4
$33.3K Sell
4,133
-293
-7% -$2.42K ﹤0.01% 1643
2024
Q3
$36.1K Buy
4,426
+312
+8% +$2.06K ﹤0.01% 1622
2024
Q2
$28.7K Buy
4,114
+523
+15% +$3.96K ﹤0.01% 1696
2024
Q1
$38.1K Sell
3,591
-62
-2% -$542 ﹤0.01% 1536
2023
Q4
$29.3K Sell
3,653
-2
-0.1% -$15 ﹤0.01% 1646
2023
Q3
$30K Hold
3,655
﹤0.01% 1515
2023
Q2
$29.2K Sell
3,655
-384
-10% -$2.83K ﹤0.01% 1518
2023
Q1
$32.7K Hold
4,039
﹤0.01% 1455
2022
Q4
$25.4K Sell
4,039
-1,812
-31% -$12.7K ﹤0.01% 1539
2022
Q3
$40K Buy
5,851
+4,726
+420% +$32.8K 0.01% 1157
2022
Q2
$9K Sell
1,125
-1,863
-62% -$26K ﹤0.01% 1698
2022
Q1
$68K Sell
2,988
-953
-24% -$23.3K 0.01% 812
2021
Q4
$109K Buy
3,941
+1,005
+34% +$26.9K 0.01% 629
2021
Q3
$82K Buy
2,936
+175
+6% +$4.96K 0.01% 685
2021
Q2
$81K Buy
2,761
+490
+22% +$14.8K 0.01% 676
2021
Q1
$72K Buy
2,271
+192
+9% +$5.63K 0.01% 688
2020
Q4
$43K Buy
2,079
+652
+46% +$12.2K 0.01% 796
2020
Q3
$22K Buy
1,427
+95
+7% +$1.64K ﹤0.01% 914
2020
Q2
$24K Sell
1,332
-2,957
-69% -$52.1K 0.01% 983
2020
Q1
$65K Buy
4,289
+160
+4% +$3.86K 0.01% 752
2019
Q4
$122K Sell
4,129
-5,002
-55% -$130K 0.01% 867
2019
Q3
$196K Hold
9,131
0.03% 606
2019
Q2
$228K Buy
9,131
+1,497
+20% +$35.5K 0.04% 504
2019
Q1
$186K Buy
7,634
+1,684
+28% +$40.2K 0.03% 526
2018
Q4
$105K Buy
5,950
+1,211
+26% +$28.8K 0.03% 581
2018
Q3
$118K Hold
4,739
0.03% 357
2018
Q2
$108K Buy
4,739
+182
+4% +$3.76K 0.04% 376
2018
Q1
$71K Hold
4,557
0.03% 520
2017
Q4
$92K Hold
4,557
0.04% 424
2017
Q3
$63K Hold
4,557
0.03% 529
2017
Q2
$77K Buy
4,557
+4,206
+1,198% +$50.4K 0.03% 411
2017
Q1
$3K Buy
351
+318
+964% +$4.38K ﹤0.01% 1475
2016
Q4
$0 Buy
33
+7
+27% +$128 ﹤0.01% 2004
2016
Q3
$0 Sell
26
-33
-56% -$854 ﹤0.01% 1999
2016
Q2
$0 Sell
59
-106
-64% -$3K ﹤0.01% 1981
2016
Q1
$3K Buy
165
+73
+79% +$5.4K ﹤0.01% 1268
2015
Q4
$6K Buy
92
+61
+197% +$6.85K ﹤0.01% 969
2015
Q3
$5K Sell
31
-2
-6% -$466 ﹤0.01% 804
2015
Q2
$7K Buy
+33
New +$7.32K ﹤0.01% 769

Other funds holding BHC

Quadrant Capital Group's BHC Position: Q1 2026 in Review

Quadrant Capital Group reduced its Bausch Health (BHC) stake by 69% in Q1 2026, selling an estimated $7.25K and leaving 538 shares worth $2.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Quadrant Capital Group first reported a position in BHC in Q2 2015 and has held it in 43 quarters since. The position peaked at $228K in Q2 2019. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Quadrant Capital Group held 538 shares of Bausch Health worth $2.91K as of Q1 2026.
  • Quadrant Capital Group sold 1,211 Bausch Health shares in Q1 2026, an estimated $7.25K.
  • Bausch Health made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2455 holding.
  • Quadrant Capital Group first reported a position in Bausch Health in Q2 2015 and has held it in 43 quarters since.
  • Quadrant Capital Group's Bausch Health position peaked at $228K in Q2 2019.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.